Stock USRM U.S. STEM CELL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart U.S. Stem Cell, Inc.

Equities

USRM

US90350U1007

Market Closed - OTC Markets
Other stock markets
 19:22:03 31/05/2024 BST 		5-day change 1st Jan Change
0.0001 USD +9,900.00% Intraday chart for U.S. Stem Cell, Inc. -.--% +9,900.00%
2023 U.S. Stem Cell, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
2023 U.S. Stem Cell, Inc. Auditor Raises 'Going Concern' Doubt CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
U.S. STEM CELL, INC. Stock U.S. Stem Cell, Inc.
 66.15K - - - - -
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
 16.37B
  1. Stock Market
  2. Equities
  3. USRM Stock
  4. Charts U.S. Stem Cell, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW